Our M&A lawyers are among the most experienced and effective in the world. We represent many of the world's largest publicly traded and privately held companies, as well as leading private equity firms on their most important mergers, acquisitions and takeover transactions.
The Medicines Company to Be Acquired by Novartis in $9.7 Billion Deal
- Client News
- November 24, 2019
Paul, Weiss is advising The Medicines Company in its all-cash $9.7 billion acquisition by Swiss pharmaceutical giant Novartis AG. Under the terms of the agreement, Novartis agreed to pay $85 per share, representing a 45 percent premium to its unaffected share price and a 57 percent premium to its unaffected one-week average price.
The Paul, Weiss team includes, among others, corporate partners Scott Barshay, Jeffrey Marell, Manuel Frey and John Kennedy and counsel Patricia Vaz de Almeida; employee benefits partner Jean McLoughlin; intellectual property partner Chuck Googe; real estate partner Peter Fisch; tax partner Jeffrey Samuels; international trade counsel Richard Elliott; antitrust counsel Marta Kelly; and environmental counsel William O’Brien.